Green Thumb Industries (GTBIF) Cash & Current Investments (2018 - 2026)
Green Thumb Industries' (GTBIF) quarterly Cash & Current Investments came in at $344.5 million in Q1 2026, up 63.6% YoY from $210.6 million in Q1 2025, and up 25.6% on a QoQ basis from $274.3 million in Q4 2025.
Green Thumb Industries (GTBIF) Cash & Current Investments (2018 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 9 years of Cash & Current Investments data on file, last reported at $344.5 million in Q1 2026.
- Quarterly Cash & Current Investments rose 63.6% year-over-year to $344.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $344.5 million (up 63.6% YoY) and the FY2025 annual result came in at $274.3 million, up 59.77% from the prior year.
- Cash & Current Investments grew to $344.5 million in Q1 2026, from $274.3 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $344.5 million in Q1 2026 to a low of $136.8 million in Q3 2023.
- A 5-year average of $192.7 million and a median of $176.9 million in 2025 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments plunged 59.55% — and 2026, when it surged 63.6%.
- Tracing GTBIF's Cash & Current Investments over 5 years: stood at $177.7 million in 2022, then decreased by 9.03% to $161.6 million in 2023, then gained by 6.22% to $171.7 million in 2024, then jumped by 59.77% to $274.3 million in 2025, then advanced by 25.6% to $344.5 million in 2026.
- The last three Cash & Current Investments figures came in at $344.5 million (Q1 2026), $274.3 million (Q4 2025), and $226.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 164.00 Mn |
| 10 | Green Thumb Industries | 1.69 Bn | 1.41 Bn | 137.87 Mn | 283.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 283.59 Mn |
| Mar 31, 2026 | 344.51 Mn |
| Dec 31, 2025 | 274.30 Mn |
| Sep 30, 2025 | 226.21 Mn |
| Jun 30, 2025 | 176.92 Mn |
| Mar 31, 2025 | 210.58 Mn |
| Dec 31, 2024 | 171.69 Mn |
| Sep 30, 2024 | 173.64 Mn |
| Jun 30, 2024 | 196.14 Mn |
| Mar 31, 2024 | 223.94 Mn |
| Dec 31, 2023 | 161.63 Mn |
| Sep 30, 2023 | 136.84 Mn |
| Jun 30, 2023 | 149.03 Mn |
| Mar 31, 2023 | 185.37 Mn |
| Dec 31, 2022 | 177.68 Mn |
| Sep 30, 2022 | 147.26 Mn |
| Jun 30, 2022 | 145.28 Mn |
| Mar 31, 2022 | 174.54 Mn |
| Dec 31, 2021 | 230.42 Mn |
| Sep 30, 2021 | 285.79 Mn |